アドレナリンβ-遮断薬o-[3-(tert-Butylamino)-2-hydroxypropoxy]benzonitrile(Bunitrolol)の代謝に及ぼす投与経路の影響

スポンサーリンク

概要

• 論文の詳細を見る

• The metabolic fate of o-[3-(tert-butylamino)-2-hydroxypropoxyl] benzonitrile (Bunitrolol) in the rat was studied by using the drug labeled with ^<14>C in the nitrile group. Urine samples collected for 24 hr after oral or intravenous administration contained about 60% of the dosed ^<14>C. The amount of unchanged Bunitrolol in urine was small after both routes of administration. The major metabolite was conjugated 4-hydroxybunitrolol, which constituted about 90% of the urinary ^<14>C after oral administration and about 70% after intravenous administration. The amount of free 4-hydroxybunitrolol was relatively small. The sum of the recovery of 4-hydroxybunitrolol and conjugated 4-hydroxybunitrolol was almost equal after both routes of administration. Two minor metabolites were detected. One of them was conjugated 2-hydroxybenzonitrile and the other was probably 3-(2-cyanophenoxy)-2-hydroxypropionic acid. Most of the metabolites in bile was conjugated 4-hydroxybunitrolol. Blood concentration of free 4-hydroxybunitrolol in the postdistributive phase was about 25-33% of the corresponding values of the parent drug after oral administration and about 5-9% after intravenous administration. These findings were different from the fact that 4-hydroxypropranolol was detected in the systemic circulation after oral administration of propranolol but not after intravenous administration. This difference would be explained by the predominant biotransformation of bunitrolol to 4-hydroxybunitrolol.

• 公益社団法人日本薬学会の論文
• 1978-09-25

著者

• 力久 忠昭

  Faculty Of Pharmaceutical Sciences University Of Chiba

• 鈴木 徳治

  Faculty of Pharmaceutical Sciences, Chiba University

• 鈴木 徳治

  千葉大 薬

• 鈴木 徳治

  千葉大学薬学部

• 森 睦博

  Faculty of Pharmaceutical Sciences, University of Chiba

• 力久 忠昭

  千葉大学薬学部

• 富山 信次

  千葉大学薬学部

• 森 睦博

  千葉大学薬学部

• 森 睦博

  Faculty Of Pharmaceutical Sciences University Of Chiba

関連論文

• A NEW STATISTICAL PROCEDURE OF INTERVAL HYPOTHESIS TESTING FOR BIOEQUIVALENCE STUDIES
• 2-(3-Pyridyl)thiazolidine-4-carboxamide Derivatives. II. Structure-Activity Relationships and Active Configuration of 2-(3-Pyridyl)thiazolidine-4-carboxamides as Platelet-Activating Factor Receptor Antagonists
• Synthesis and Biological Activity of the Metabolites of N-[2-(1-Azabicyclo[3.3.0]octan-5-yl)ethyl]-2-nitroaniline Fumarate (SK-946)
• Synthesis of (1-Azabicyclo[3.3.0]octanyl)methyl-Substituted Aromatic Heterocycles and Their Muscarinic Activity
• Determination of Phenylbutazone and Its Metabolites in Plasma by Gas-Liquid Chromatographic Procedure
• An Improved Synthesis of Butyl 4-[(4-Amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (AU-224)
• Structure-Activity Relationship(SAR)Studies on Oxazolidinone Antibacterial Agents.1. Conversion of 5-Substituent on Oxazolidinone
• 薬物のBioavailability (最新薬物療法manual--投薬の基本と治療プログラム) -- (薬物投与の基礎理論--PharmacokineticsとPharmacodynamics)
• 製剤の進歩による新しい薬剤 (新しい薬--その開発と臨床応用)
• Characterization of the Neurochemical Effects of N-[2-(1-azabicyclo[3,3,0]octan-5-yl)ethyl]2-nitroaniline fumarate (SK-946) as a Cognition Activator
• Simple Method for Repetitive Blood Sampling in a Self-Controlled Design in the Rat
• Drug Absorption and Metabolism Studies by Use of Portal Vein Infusion in the Rat. II. Influence of Dose and Infusion Rate on the Bioavailability of Propranolol
• Pharmacokinetic Analysis of Blood Level Data interpreted by a Two-Compartment Model
• Drug Absorption and Metabolism Studies by Use of Portal Vein Infusion in the Rat. I. Pyloric Vein Cannulation and Its Application to Study of First-Pass Effect on Bioavailability of Propranolol
• インスリンの消化管吸収に対するキモトリプシン阻害剤FK-448の増強作用
• New Approach to the Hepatic First-Pass Effect by Whole-Body Autoradiography
• Immunoliposome-Mediated Gene Transfer into Cultured Myotubes
• Examination of Local Anti-inflammatory Activities of New Steroids, Hemisuccinyl Methyl Glycolates
• 学生のためのカウンセリング
• Pharmacokineticsに関する教科書
• 薬学会主導による医薬品問題の検討を(日医・医薬品長期対策委の「新しい視点からの医薬品開発」について)
• アドレナリンβ-遮断薬o-[3-(tert-Butylamino)-2-hydroxypropoxy]benzonitrile(Bunitrolol)の代謝に及ぼす投与経路の影響
• マイクロコンピュータを用いたシンプレックス法による薬物速度論的パラメータの推定
• Modification by Fluoride, Bromide, Iodide, Thiocyanate and Nitrite Anions of Reaction of a Myeloperoxidase-H_2O_2-Cl^- System with Nucleosides
• Effects of Fluvastatin and Its Major Metabolites on Low-Density Lipoprotein Oxidation and Cholesterol Esterification in Macrophages
• Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL from Oxidative Modification in Hypercholesterolemic Rabbits
• In Vitro Inhibitory Effects of the Optical Isomers and Metabolites of Fluvastatin on Copper Ion-Induced LDL Oxidation
• An in Vitro Study of the Hydroxyl Radical Scavengin Property of Fluvastatin, and HMG-CoA Reductase Inhibitor
• 生物学的同等性の判定における仮説検定法, 区間推定法, 及びBayes流の解析法の比較
• 初回通過効果 : 生物学的利用性に影響する要因
• Inhibitory Effects of Fidarestat on Aldose Reductase and Aldehyde Reductase Activity Evaluated by a New Method Using HPLC with Post-column Spectrophotometric Detection
• 2-(3-Pyridyl)thiazolidine-4-carboxamide Derivatives. III. Synthesis of Metabolites and Metabolism of 2-(3-Pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as Platelet-Activating Factor (PAF) Receptor Antagonists
• Studies on Decomposition and Stabilization of Drugs in Solution. XVIII. The Hydrolysis of Phthalylsulfathiazole
• Thiamine Derivatives of Disulfide Type. XV. The Ring Opening-closing Reactions of 4-Methylthiazolium Salts
• Synthesis of the Selective 5-Hydroxytryptamine 4 (5-HT_4) Receptor Agonist (+)-(S)-2-Chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-yl]aniline
• Intramolecular Oxymercuration with Mercuric Triflate
• Mercuric Triflate-TMU Catalyzed Hydration of Terminal Alkyne to give Methyl Ketone under Mild Conditions
• Effects of N-[2-(1-Azabicyclo[3,3,0]octan-5-yl)ethyl]2-nitroaniline Fumarate (SK-946), a Novel Cognition Activator, on Learning and Memory in Rodent Models
• Novel 5-Hydroxytryptamine 4 (5-HT_4) Receptor Agonists. Synthesis and Gastroprokinetic Activity of 4-Amino-N-[2-(1-aminocycloalkan-1-yl)ethyl]-5-chloro-2-methoxybenzamides
• Effect of repeated administration of propranolol on liver metabolism and its factors.
• Effect of repeated administration of propranolol on non-linear first pass metabolism.
• Strain specificity of metabolism of propranolol and lidocaine in rats.
• Problems with pharmacotherapy in elderly patients. 1. Specificity of variation in metabolic activities accompanying senile change.
• タイトル無し

もっと見る 閉じる

スポンサーリンク